Summit Therapeutics shares rise after the company says AstraZeneca will make a $2 billion strategic equity investment to help jointly develop drugs with the cancer drugmaker.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0